Yoshifumi Shimada
Niigata University · 373 works · 5,011 citations · h-index 41
Top works
- Spectrophotometric monitoring of arterial oxygen saturation in the fingertip
- Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.
- Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)
- Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome
- Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
- FGFR2 gene amplification and clinicopathological features in gastric cancer
- “Loop Clip”, a new closure device for large mucosal defects after EMR and ESD
- Three Cases of Iatrogenic Coronary Ostial Stenosis After Aortic Valve Replacement
- Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil
- Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
- Evaluation of a hot-wire respiratory flowmeter for clinical applicability
- Efficacy of CPT-11 (Irinotecan) as a Single Agent in Metastatic Colorectal Cancer
- Management of rectal gastrointestinal stromal tumor
- Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
- Next generation sequencing‐based gene panel tests for the management of solid tumors
- Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer
- Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
- Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma
- Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
- Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma